The cost and challenge of vaccine development for emerging and emergent infectious diseases

Lancet Glob Health. 2018 Dec;6(12):e1266-e1267. doi: 10.1016/S2214-109X(18)30418-2. Epub 2018 Oct 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Communicable Diseases*
  • Coronavirus Infections / prevention & control*
  • Epidemics*
  • Humans
  • Vaccines / immunology*

Substances

  • Vaccines